Content: MOTOR NEURON
DISEASE – FOR NEET PG/FMGE
Impaired neuronal viability is due to:
For
understanding in the video, visit our YouTube channel: YOUTUBE
Definition:
It is the disease of motor neurons.
It is an irreversible loss of motor neurons and gliosis; in motor cortex, motor nuclei of brainstem and anterior horn of spinal cord.
It is an irreversible loss of motor neurons and gliosis; in motor cortex, motor nuclei of brainstem and anterior horn of spinal cord.
It can
affect any age but most patients are over 40 years old at the time of
diagnosis.
90% MNDs are
sporadic in nature.
There won’t
be any sensory involvement.
Nomenclature:
1. UMN lesion of Cortico-bulbar tract:
Pseudo Bulbar Palsy.
2. LMN lesion Cortico-bulbar tract:
Progressive Bulbar Palsy.
3. UMN lesion of corticospinal tract:
Primary Lateral Sclerosis.
4. LMN lesion of corticospinal tract:
Progressive Spinal Muscle Atrophy.
5. Both UMN and LMN involvement:
Amyotrophic Lateral Sclerosis.
Points
about: ALS
-
Most
common type of MND.
-
Men
> Women.
-
Smoking
– Independent risk factor for sporadic ALS.
-
SPLIT
HAND phenomenon: Severe changes in thenar eminence and the relative sparing of
hypothenar eminence, observed in EMG study.
-
Coronal
T2WI MRI: Bilateral symmetrical hyper intensity along corticospinal tracts
forming a ‘Wine Glass’ appearance.
Impaired neuronal viability is due to:
-
Superoxide
dismutase 1 transgenes.
-
Hexanucleotide
repeats.
-
ALS
gene leading to defective axonal cytoskeleton.
Clinical Features:
-
Asymmetric
muscle weakness.
-
Normal
sensations.
-
Difficulty
in swallowing, chewing and tongue movements. Tongue fasciculation may be
present.
-
Death
is due to respiratory failure.
Normal in
MNDs:
-
Eye
movement.
-
Bladder
and bowel.
-
Mentation.
-
Sexual
function.
Investigations:
-
EMG:
Most confirmatory.
-
Biopsy
shows atrophy.
-
Diagnosis
is considered definitive if 3 out of 4 areas are involved: bulbar, cervical, and
thoracic and lumbosacral motor neurons.
Drugs:
-
Riluzole:
Reduces glutamate induced exitotoxicity.
Recommended dose is 100mg per day.
Reduces glutamate induced exitotoxicity.
Recommended dose is 100mg per day.
-
Edavarone:
Free radical scavenging agent.
It just slows the disease progression. Recommended dose is 30 – 60 mg per day IV Infusion.
It just slows the disease progression. Recommended dose is 30 – 60 mg per day IV Infusion.
_
_____________________________________
I hope you
liked the notes.
Please like
and share the link as much as possible.
For more
content: Subscribe our YouTube channel:

No comments:
Post a Comment